10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0000049071-23-000064 |
| Period End Date | 20230930 |
| Filing Date | 20231101 |
| Fiscal Year | 2023 |
| Fiscal Period | Q3 |
| XBRL Instance | hum-20230930_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
82 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Receivables, net of allowances |
AllowanceForDoubtfulAccountsReceivableCurrent
|
$70.00M | USD | Point-in-time |
| Receivables, net of allowances |
AllowanceForDoubtfulAccountsReceivableCurrent
|
$73.00M | USD | Point-in-time |
| Preferred stock, par (in dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$1.00 | USD | Point-in-time |
| Preferred stock, par (in dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$1.00 | USD | Point-in-time |
| Preferred stock, shares authorized (in shares) |
PreferredStockSharesAuthorized
|
10.00M | shares | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$15.15B | USD | Point-in-time |
| Preferred stock, shares authorized (in shares) |
PreferredStockSharesAuthorized
|
10.00M | shares | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$5.06B | USD | Point-in-time |
| Preferred stock, shares issued (in shares) |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Investment securities |
ShortTermInvestments
|
$15.14B | USD | Point-in-time |
| Preferred stock, shares issued (in shares) |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Investment securities |
ShortTermInvestments
|
$13.88B | USD | Point-in-time |
| Receivables, net of allowances of $73 in 2023 and $70 in 2022 |
ReceivablesNetCurrent
|
$1.82B | USD | Point-in-time |
| Receivables, net of allowances of $73 in 2023 and $70 in 2022 |
ReceivablesNetCurrent
|
$1.67B | USD | Point-in-time |
| Common stock, par (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.17 | USD | Point-in-time |
| Common stock, par (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.17 | USD | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$5.57B | USD | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
300.00M | shares | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$6.14B | USD | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
300.00M | shares | Point-in-time |
| Total current assets |
AssetsCurrent
|
$26.18B | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$38.25B | USD | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
198.67M | shares | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
198.69M | shares | Point-in-time |
| Treasury stock, shares (in shares) |
TreasuryStockCommonShares
|
75.58M | shares | Point-in-time |
| Treasury stock, shares (in shares) |
TreasuryStockCommonShares
|
73.69M | shares | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$3.34B | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$3.22B | USD | Point-in-time |
| Long-term investment securities |
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
|
$380.00M | USD | Point-in-time |
| Long-term investment securities |
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
|
$370.00M | USD | Point-in-time |
| Equity method investments |
EquityMethodInvestments
|
$762.00M | USD | Point-in-time |
| Equity method investments |
EquityMethodInvestments
|
$749.00M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$9.14B | USD | Point-in-time |
| Goodwill |
Goodwill
|
$9.54B | USD | Point-in-time |
| Other long-term assets |
OtherAssetsNoncurrent
|
$3.64B | USD | Point-in-time |
| Other long-term assets |
OtherAssetsNoncurrent
|
$3.38B | USD | Point-in-time |
| Total assets |
Assets
|
$43.05B | USD | Point-in-time |
| Total assets |
Assets
|
$55.91B | USD | Point-in-time |
| Benefits payable |
LiabilityForClaimsAndClaimsAdjustmentExpense
|
$10.20B | USD | Point-in-time |
| Benefits payable |
LiabilityForClaimsAndClaimsAdjustmentExpense
|
$9.26B | USD | Point-in-time |
| Benefits payable |
LiabilityForClaimsAndClaimsAdjustmentExpense
|
$8.29B | USD | Point-in-time |
| Benefits payable |
LiabilityForClaimsAndClaimsAdjustmentExpense
|
$9.24B | USD | Point-in-time |
| Trade accounts payable and accrued expenses |
AccountsPayableAndAccruedLiabilitiesCurrent
|
$5.24B | USD | Point-in-time |
| Trade accounts payable and accrued expenses |
AccountsPayableAndAccruedLiabilitiesCurrent
|
$7.60B | USD | Point-in-time |
| Book overdraft |
BookOverdraftLiability
|
$298.00M | USD | Point-in-time |
| Book overdraft |
BookOverdraftLiability
|
$246.00M | USD | Point-in-time |
| Unearned revenues |
ContractWithCustomerLiabilityCurrent
|
$286.00M | USD | Point-in-time |
| Unearned revenues |
ContractWithCustomerLiabilityCurrent
|
$7.54B | USD | Point-in-time |
| Short-term debt |
DebtCurrent
|
$2.25B | USD | Point-in-time |
| Short-term debt |
DebtCurrent
|
$2.09B | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$27.82B | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$17.18B | USD | Point-in-time |
| Long-term debt |
LongTermDebtNoncurrent
|
$9.48B | USD | Point-in-time |
| Long-term debt |
LongTermDebtNoncurrent
|
$9.03B | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$1.59B | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$1.47B | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$27.68B | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$38.90B | USD | Point-in-time |
| Preferred stock, $1 par; 10,000,000 shares authorized; none issued |
PreferredStockValue
|
- | USD | Point-in-time |
| Preferred stock, $1 par; 10,000,000 shares authorized; none issued |
PreferredStockValue
|
- | USD | Point-in-time |
| Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,690,082 shares issued at September 30, 2023 and 198,666,598 shares issued at December 31, 2022 |
CommonStockValue
|
$33.00M | USD | Point-in-time |
| Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,690,082 shares issued at September 30, 2023 and 198,666,598 shares issued at December 31, 2022 |
CommonStockValue
|
$33.00M | USD | Point-in-time |
| Capital in excess of par value |
AdditionalPaidInCapitalCommonStock
|
$3.25B | USD | Point-in-time |
| Capital in excess of par value |
AdditionalPaidInCapitalCommonStock
|
$3.36B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$28.19B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$25.49B | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-1.30B | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-1.50B | USD | Point-in-time |
| Treasury stock, at cost, 75,579,362 shares at September 30, 2023 and 73,691,955 shares at December 31, 2022 |
TreasuryStockCommonValue
|
$13.13B | USD | Point-in-time |
| Treasury stock, at cost, 75,579,362 shares at September 30, 2023 and 73,691,955 shares at December 31, 2022 |
TreasuryStockCommonValue
|
$12.16B | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$15.31B | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$16.95B | USD | Point-in-time |
| Noncontrolling interests |
MinorityInterest
|
$59.00M | USD | Point-in-time |
| Noncontrolling interests |
MinorityInterest
|
$55.00M | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$16.89B | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$16.10B | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$16.32B | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$15.51B | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$17.00B | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$15.37B | USD | Point-in-time |
| Total liabilities and equity |
LiabilitiesAndStockholdersEquity
|
$43.05B | USD | Point-in-time |
| Total liabilities and equity |
LiabilitiesAndStockholdersEquity
|
$55.91B | USD | Point-in-time |
Income Statement
80 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Premiums |
PremiumsEarnedNet
|
$25.10B | USD | 1 Quarter |
| Premiums |
PremiumsEarnedNet
|
$21.47B | USD | 1 Quarter |
| Premiums |
PremiumsEarnedNet
|
$66.44B | USD | 3 Qtrs |
| Premiums |
PremiumsEarnedNet
|
$76.14B | USD | 3 Qtrs |
| Services |
RevenueFromContractWithCustomerIncludingAssessedTax
|
$1.02B | USD | 1 Quarter |
| Services |
RevenueFromContractWithCustomerIncludingAssessedTax
|
$3.77B | USD | 3 Qtrs |
| Services |
RevenueFromContractWithCustomerIncludingAssessedTax
|
$1.16B | USD | 1 Quarter |
| Services |
RevenueFromContractWithCustomerIncludingAssessedTax
|
$2.99B | USD | 3 Qtrs |
| Investment income |
InvestmentIncomeInterestAndDividend
|
$172.00M | USD | 1 Quarter |
| Investment income |
InvestmentIncomeInterestAndDividend
|
$308.00M | USD | 1 Quarter |
| Investment income |
InvestmentIncomeInterestAndDividend
|
$222.00M | USD | 3 Qtrs |
| Investment income |
InvestmentIncomeInterestAndDividend
|
$775.00M | USD | 3 Qtrs |
| Total revenues |
Revenues
|
$22.80B | USD | 1 Quarter |
| Total revenues |
Revenues
|
$79.91B | USD | 3 Qtrs |
| Total revenues |
Revenues
|
$70.43B | USD | 3 Qtrs |
| Total revenues |
Revenues
|
$26.42B | USD | 1 Quarter |
| Benefits |
PolicyholderBenefitsAndClaimsIncurredHealthCare
|
$21.75B | USD | 1 Quarter |
| Benefits |
PolicyholderBenefitsAndClaimsIncurredHealthCare
|
$65.61B | USD | 3 Qtrs |
| Benefits |
PolicyholderBenefitsAndClaimsIncurredHealthCare
|
$57.11B | USD | 3 Qtrs |
| Benefits |
PolicyholderBenefitsAndClaimsIncurredHealthCare
|
$18.38B | USD | 1 Quarter |
| Operating costs |
SellingGeneralAndAdministrativeExpense
|
$3.27B | USD | 1 Quarter |
| Operating costs |
SellingGeneralAndAdministrativeExpense
|
$3.06B | USD | 1 Quarter |
| Operating costs |
SellingGeneralAndAdministrativeExpense
|
$9.12B | USD | 3 Qtrs |
| Operating costs |
SellingGeneralAndAdministrativeExpense
|
$9.36B | USD | 3 Qtrs |
| Depreciation and amortization |
DepreciationAndAmortizationIncomeStatement
|
$527.00M | USD | 3 Qtrs |
| Depreciation and amortization |
DepreciationAndAmortizationIncomeStatement
|
$578.00M | USD | 3 Qtrs |
| Depreciation and amortization |
DepreciationAndAmortizationIncomeStatement
|
$201.00M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationAndAmortizationIncomeStatement
|
$182.00M | USD | 1 Quarter |
| Total operating expenses |
BenefitsLossesAndExpenses
|
$75.55B | USD | 3 Qtrs |
| Total operating expenses |
BenefitsLossesAndExpenses
|
$66.75B | USD | 3 Qtrs |
| Total operating expenses |
BenefitsLossesAndExpenses
|
$21.63B | USD | 1 Quarter |
| Total operating expenses |
BenefitsLossesAndExpenses
|
$25.22B | USD | 1 Quarter |
| Income (loss) from operations |
OperatingIncomeLoss
|
$1.21B | USD | 1 Quarter |
| Income (loss) from operations |
OperatingIncomeLoss
|
$3.68B | USD | 3 Qtrs |
| Income (loss) from operations |
OperatingIncomeLoss
|
$4.36B | USD | 3 Qtrs |
| Income (loss) from operations |
OperatingIncomeLoss
|
$1.17B | USD | 1 Quarter |
| Gain on sale of Gentiva Hospice |
GainLossOnSaleOfBusiness
|
$240.00M | USD | 3 Qtrs |
| Gain on sale of Gentiva Hospice |
GainLossOnSaleOfBusiness
|
$240.00M | USD | 1 Quarter |
| Gain on sale of Gentiva Hospice |
GainLossOnSaleOfBusiness
|
- | USD | 1 Quarter |
| Gain on sale of Gentiva Hospice |
GainLossOnSaleOfBusiness
|
- | USD | 3 Qtrs |
| Interest expense |
InterestExpense
|
$102.00M | USD | 1 Quarter |
| Interest expense |
InterestExpense
|
$293.00M | USD | 3 Qtrs |
| Interest expense |
InterestExpense
|
$347.00M | USD | 3 Qtrs |
| Interest expense |
InterestExpense
|
$114.00M | USD | 1 Quarter |
| Other (income) expense, net |
OtherNonoperatingIncomeExpense
|
$16.00M | USD | 3 Qtrs |
| Other (income) expense, net |
OtherNonoperatingIncomeExpense
|
$6.00M | USD | 1 Quarter |
| Other (income) expense, net |
OtherNonoperatingIncomeExpense
|
$-40.00M | USD | 3 Qtrs |
| Other (income) expense, net |
OtherNonoperatingIncomeExpense
|
$-13.00M | USD | 1 Quarter |
| Income (loss) before income taxes and equity in net losses |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$3.97B | USD | 3 Qtrs |
| Income (loss) before income taxes and equity in net losses |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$3.64B | USD | 3 Qtrs |
| Income (loss) before income taxes and equity in net losses |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$1.30B | USD | 1 Quarter |
| Income (loss) before income taxes and equity in net losses |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$1.10B | USD | 1 Quarter |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
$256.00M | USD | 1 Quarter |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
$820.00M | USD | 3 Qtrs |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
$911.00M | USD | 3 Qtrs |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
$107.00M | USD | 1 Quarter |
| Equity in net (losses) earnings |
IncomeLossFromEquityMethodInvestments
|
$3.00M | USD | 1 Quarter |
| Equity in net (losses) earnings |
IncomeLossFromEquityMethodInvestments
|
$1.00M | USD | 3 Qtrs |
| Equity in net (losses) earnings |
IncomeLossFromEquityMethodInvestments
|
$-12.00M | USD | 1 Quarter |
| Equity in net (losses) earnings |
IncomeLossFromEquityMethodInvestments
|
$-39.00M | USD | 3 Qtrs |
| Net income |
ProfitLoss
|
$1.19B | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$830.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$2.82B | USD | 3 Qtrs |
| Net income |
ProfitLoss
|
$3.02B | USD | 3 Qtrs |
| Net loss attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-6.00M | USD | 3 Qtrs |
| Net loss attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-1.00M | USD | 3 Qtrs |
| Net loss attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-2.00M | USD | 1 Quarter |
| Net loss attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-2.00M | USD | 1 Quarter |
| Net income attributable to Humana |
NetIncomeLoss
|
$1.20B | USD | 1 Quarter |
| Net income attributable to Humana |
NetIncomeLoss
|
$3.03B | USD | 3 Qtrs |
| Net income attributable to Humana |
NetIncomeLoss
|
$2.82B | USD | 3 Qtrs |
| Net income attributable to Humana |
NetIncomeLoss
|
$832.00M | USD | 1 Quarter |
| Basic earnings per common share (in dollars per share) |
EarningsPerShareBasic
|
$9.45 | USD | 1 Quarter |
| Basic earnings per common share (in dollars per share) |
EarningsPerShareBasic
|
$22.27 | USD | 3 Qtrs |
| Basic earnings per common share (in dollars per share) |
EarningsPerShareBasic
|
$24.37 | USD | 3 Qtrs |
| Basic earnings per common share (in dollars per share) |
EarningsPerShareBasic
|
$6.74 | USD | 1 Quarter |
| Diluted earnings per common share (in dollars per share) |
EarningsPerShareDiluted
|
$24.26 | USD | 3 Qtrs |
| Diluted earnings per common share (in dollars per share) |
EarningsPerShareDiluted
|
$9.39 | USD | 1 Quarter |
| Diluted earnings per common share (in dollars per share) |
EarningsPerShareDiluted
|
$6.71 | USD | 1 Quarter |
| Diluted earnings per common share (in dollars per share) |
EarningsPerShareDiluted
|
$22.16 | USD | 3 Qtrs |
Cash Flow Statement
98 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income |
ProfitLoss
|
$1.19B | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$830.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$2.82B | USD | 3 Qtrs |
| Net income |
ProfitLoss
|
$3.02B | USD | 3 Qtrs |
| Gain on sale of Gentiva Hospice |
GainLossOnSaleOfBusiness
|
- | USD | 1 Quarter |
| Gain on sale of Gentiva Hospice |
GainLossOnSaleOfBusiness
|
- | USD | 3 Qtrs |
| Gain on sale of Gentiva Hospice |
GainLossOnSaleOfBusiness
|
$240.00M | USD | 3 Qtrs |
| Gain on sale of Gentiva Hospice |
GainLossOnSaleOfBusiness
|
$240.00M | USD | 1 Quarter |
| Loss on investment securities, net |
DebtAndEquitySecuritiesGainLoss
|
$-49.00M | USD | 3 Qtrs |
| Loss on investment securities, net |
DebtAndEquitySecuritiesGainLoss
|
$-4.00M | USD | 1 Quarter |
| Loss on investment securities, net |
DebtAndEquitySecuritiesGainLoss
|
$1.00M | USD | 1 Quarter |
| Loss on investment securities, net |
DebtAndEquitySecuritiesGainLoss
|
$-136.00M | USD | 3 Qtrs |
| Equity in net losses (earnings) |
IncomeLossFromEquityMethodInvestments
|
$3.00M | USD | 1 Quarter |
| Equity in net losses (earnings) |
IncomeLossFromEquityMethodInvestments
|
$1.00M | USD | 3 Qtrs |
| Equity in net losses (earnings) |
IncomeLossFromEquityMethodInvestments
|
$-12.00M | USD | 1 Quarter |
| Equity in net losses (earnings) |
IncomeLossFromEquityMethodInvestments
|
$-39.00M | USD | 3 Qtrs |
| Stock-based compensation |
ShareBasedCompensation
|
$142.00M | USD | 3 Qtrs |
| Stock-based compensation |
ShareBasedCompensation
|
$173.00M | USD | 3 Qtrs |
| Depreciation |
Depreciation
|
$628.00M | USD | 3 Qtrs |
| Depreciation |
Depreciation
|
$555.00M | USD | 3 Qtrs |
| Amortization |
AdjustmentForAmortization
|
$73.00M | USD | 3 Qtrs |
| Amortization |
AdjustmentForAmortization
|
$51.00M | USD | 3 Qtrs |
| Impairment of property and equipment |
TangibleAssetImpairmentCharges
|
$31.00M | USD | 3 Qtrs |
| Impairment of property and equipment |
TangibleAssetImpairmentCharges
|
$144.00M | USD | 3 Qtrs |
| Deferred income taxes |
DeferredIncomeTaxExpenseBenefit
|
$-33.00M | USD | 3 Qtrs |
| Deferred income taxes |
DeferredIncomeTaxExpenseBenefit
|
- | USD | 3 Qtrs |
| Receivables |
IncreaseDecreaseInReceivables
|
$126.00M | USD | 3 Qtrs |
| Receivables |
IncreaseDecreaseInReceivables
|
$-11.00M | USD | 3 Qtrs |
| Other assets |
IncreaseDecreaseInOtherOperatingAssets
|
$465.00M | USD | 3 Qtrs |
| Other assets |
IncreaseDecreaseInOtherOperatingAssets
|
$935.00M | USD | 3 Qtrs |
| Benefits payable |
IncreaseDecreaseInHealthCareInsuranceLiabilities
|
$948.00M | USD | 3 Qtrs |
| Benefits payable |
IncreaseDecreaseInHealthCareInsuranceLiabilities
|
$870.00M | USD | 3 Qtrs |
| Other liabilities |
IncreaseDecreaseInOtherOperatingLiabilities
|
$-195.00M | USD | 3 Qtrs |
| Other liabilities |
IncreaseDecreaseInOtherOperatingLiabilities
|
$39.00M | USD | 3 Qtrs |
| Unearned revenues |
IncreaseDecreaseInContractWithCustomerLiability
|
$7.25B | USD | 3 Qtrs |
| Unearned revenues |
IncreaseDecreaseInContractWithCustomerLiability
|
$5.76B | USD | 3 Qtrs |
| Other |
OtherOperatingActivitiesCashFlowStatement
|
$30.00M | USD | 3 Qtrs |
| Other |
OtherOperatingActivitiesCashFlowStatement
|
$53.00M | USD | 3 Qtrs |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$11.12B | USD | 3 Qtrs |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$9.71B | USD | 3 Qtrs |
| Proceeds from sale of Gentiva Hospice, net |
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
|
$2.71B | USD | 3 Qtrs |
| Proceeds from sale of Gentiva Hospice, net |
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
|
- | USD | 3 Qtrs |
| Acquisitions, net of cash and cash equivalents acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
$293.00M | USD | 3 Qtrs |
| Acquisitions, net of cash and cash equivalents acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
$223.00M | USD | 3 Qtrs |
| Purchases of property and equipment, net |
PaymentsToAcquirePropertyPlantAndEquipment
|
$721.00M | USD | 3 Qtrs |
| Purchases of property and equipment, net |
PaymentsToAcquirePropertyPlantAndEquipment
|
$862.00M | USD | 3 Qtrs |
| Purchases of investment securities |
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
$4.74B | USD | 3 Qtrs |
| Purchases of investment securities |
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
$3.37B | USD | 3 Qtrs |
| Proceeds from maturities of investment securities |
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
$1.21B | USD | 3 Qtrs |
| Proceeds from maturities of investment securities |
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
$885.00M | USD | 3 Qtrs |
| Proceeds from sales of investment securities |
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
$1.98B | USD | 3 Qtrs |
| Proceeds from sales of investment securities |
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
$815.00M | USD | 3 Qtrs |
| Net cash (used in) provided by investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-2.61B | USD | 3 Qtrs |
| Net cash (used in) provided by investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$6.00M | USD | 3 Qtrs |
| Receipts from contract deposits, net |
PaymentsForProceedsFromContractDeposits
|
$-3.79B | USD | 3 Qtrs |
| Receipts from contract deposits, net |
PaymentsForProceedsFromContractDeposits
|
$-2.48B | USD | 3 Qtrs |
| Proceeds from issuance of senior notes, net |
ProceedsFromIssuanceOfSeniorLongTermDebt
|
$1.22B | USD | 3 Qtrs |
| Proceeds from issuance of senior notes, net |
ProceedsFromIssuanceOfSeniorLongTermDebt
|
$744.00M | USD | 3 Qtrs |
| Repayments of senior notes |
RepaymentsOfSeniorDebt
|
$1.72B | USD | 3 Qtrs |
| Repayments of senior notes |
RepaymentsOfSeniorDebt
|
- | USD | 3 Qtrs |
| Proceeds from issuance (repayments) of commercial paper, net |
ProceedsFromRepaymentsOfCommercialPaper
|
$1.62B | USD | 3 Qtrs |
| Proceeds from issuance (repayments) of commercial paper, net |
ProceedsFromRepaymentsOfCommercialPaper
|
$-660.00M | USD | 3 Qtrs |
| Repayment of term loan |
RepaymentsOfNotesPayable
|
$500.00M | USD | 3 Qtrs |
| Repayment of term loan |
RepaymentsOfNotesPayable
|
$2.00B | USD | 3 Qtrs |
| Debt issue costs |
PaymentsOfDebtIssuanceCosts
|
$4.00M | USD | 3 Qtrs |
| Debt issue costs |
PaymentsOfDebtIssuanceCosts
|
$2.00M | USD | 3 Qtrs |
| Change in book overdraft |
IncreaseDecreaseInBookOverdrafts
|
$-89.00M | USD | 3 Qtrs |
| Change in book overdraft |
IncreaseDecreaseInBookOverdrafts
|
$-52.00M | USD | 3 Qtrs |
| Common stock repurchases |
PaymentsForRepurchaseOfCommonStock
|
$1.00B | USD | 3 Qtrs |
| Common stock repurchases |
PaymentsForRepurchaseOfCommonStock
|
$1.03B | USD | 3 Qtrs |
| Dividends paid |
PaymentsOfDividends
|
$291.00M | USD | 3 Qtrs |
| Dividends paid |
PaymentsOfDividends
|
$320.00M | USD | 3 Qtrs |
| Other |
ProceedsFromPaymentsForOtherFinancingActivities
|
$-135.00M | USD | 3 Qtrs |
| Other |
ProceedsFromPaymentsForOtherFinancingActivities
|
$-13.00M | USD | 3 Qtrs |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$1.58B | USD | 3 Qtrs |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$444.00M | USD | 3 Qtrs |
| Increase in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$10.09B | USD | 3 Qtrs |
| Increase in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$10.16B | USD | 3 Qtrs |
| Cash and cash equivalents at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$13.56B | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$15.15B | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$5.06B | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$3.39B | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$3.39B | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$5.06B | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$13.56B | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$15.15B | USD | Point-in-time |
| Interest payments |
InterestPaidNet
|
$317.00M | USD | 3 Qtrs |
| Interest payments |
InterestPaidNet
|
$256.00M | USD | 3 Qtrs |
| Income tax payments, net |
IncomeTaxesPaidNet
|
$957.00M | USD | 3 Qtrs |
| Income tax payments, net |
IncomeTaxesPaidNet
|
$751.00M | USD | 3 Qtrs |
| Fair value of assets acquired, net of cash and cash equivalents acquired |
FairValueOfAssetsAcquired
|
$454.00M | USD | 3 Qtrs |
| Fair value of assets acquired, net of cash and cash equivalents acquired |
FairValueOfAssetsAcquired
|
$411.00M | USD | 3 Qtrs |
| Less: Fair value of liabilities assumed |
LiabilitiesAssumed1
|
$236.00M | USD | 3 Qtrs |
| Less: Fair value of liabilities assumed |
LiabilitiesAssumed1
|
$65.00M | USD | 3 Qtrs |
| Less: Noncontrolling interests acquired |
NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired
|
$53.00M | USD | 3 Qtrs |
| Less: Noncontrolling interests acquired |
NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired
|
$-5.00M | USD | 3 Qtrs |
| Cash paid for acquired businesses, net of cash and cash equivalents acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
$293.00M | USD | 3 Qtrs |
| Cash paid for acquired businesses, net of cash and cash equivalents acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
$223.00M | USD | 3 Qtrs |
Stockholders Equity
48 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$16.89B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$16.10B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$16.32B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$15.51B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$17.00B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$15.37B | USD | Point-in-time |
| Net income |
ProfitLoss
|
$1.19B | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$830.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$2.82B | USD | 3 Qtrs |
| Net income |
ProfitLoss
|
$3.02B | USD | 3 Qtrs |
| Distribution from (to) noncontrolling interest holders, net |
NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders
|
$-1.00M | USD | 3 Qtrs |
| Distribution from (to) noncontrolling interest holders, net |
NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders
|
$3.00M | USD | 1 Quarter |
| Distribution from (to) noncontrolling interest holders, net |
NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders
|
$7.00M | USD | 3 Qtrs |
| Sale of Gentiva Hospice |
NoncontrollingInterestDecreaseFromDeconsolidation
|
$11.00M | USD | 3 Qtrs |
| Sale of Gentiva Hospice |
NoncontrollingInterestDecreaseFromDeconsolidation
|
$11.00M | USD | 1 Quarter |
| Acquisition |
MinorityInterestDecreaseFromRedemptions
|
$5.00M | USD | 3 Qtrs |
| Acquisition |
MinorityInterestDecreaseFromRedemptions
|
$-53.00M | USD | 3 Qtrs |
| Acquisition |
MinorityInterestDecreaseFromRedemptions
|
$-53.00M | USD | 1 Quarter |
| Other comprehensive loss |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-416.00M | USD | 1 Quarter |
| Other comprehensive loss |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-1.51B | USD | 3 Qtrs |
| Other comprehensive loss |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-199.00M | USD | 3 Qtrs |
| Other comprehensive loss |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-277.00M | USD | 1 Quarter |
| Common stock repurchases |
TreasuryStockValueAcquiredCostMethod
|
$1.03B | USD | 3 Qtrs |
| Common stock repurchases |
TreasuryStockValueAcquiredCostMethod
|
$1.01B | USD | 3 Qtrs |
| Common stock repurchases |
TreasuryStockValueAcquiredCostMethod
|
$4.00M | USD | 1 Quarter |
| Common stock repurchases |
TreasuryStockValueAcquiredCostMethod
|
$383.00M | USD | 1 Quarter |
| Dividends and dividend equivalents |
DividendsCommonStockCash
|
$100.00M | USD | 1 Quarter |
| Dividends and dividend equivalents |
DividendsCommonStockCash
|
$331.00M | USD | 3 Qtrs |
| Dividends and dividend equivalents |
DividendsCommonStockCash
|
$109.00M | USD | 1 Quarter |
| Dividends and dividend equivalents |
DividendsCommonStockCash
|
$301.00M | USD | 3 Qtrs |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$142.00M | USD | 3 Qtrs |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$80.00M | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$173.00M | USD | 3 Qtrs |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$53.00M | USD | 1 Quarter |
| Restricted stock unit vesting |
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
- | USD | 3 Qtrs |
| Restricted stock unit vesting |
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
- | USD | 1 Quarter |
| Restricted stock unit vesting |
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
- | USD | 1 Quarter |
| Restricted stock unit vesting |
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
- | USD | 3 Qtrs |
| Stock option exercises |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$9.00M | USD | 1 Quarter |
| Stock option exercises |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$22.00M | USD | 3 Qtrs |
| Stock option exercises |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$7.00M | USD | 3 Qtrs |
| Stock option exercises |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$-1.00M | USD | 1 Quarter |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$17.00B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$16.89B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$16.10B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$16.32B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$15.51B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$15.37B | USD | Point-in-time |
Comprehensive Income
36 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income attributable to Humana |
NetIncomeLoss
|
$2.82B | USD | 3 Qtrs |
| Net income attributable to Humana |
NetIncomeLoss
|
$832.00M | USD | 1 Quarter |
| Net income attributable to Humana |
NetIncomeLoss
|
$3.03B | USD | 3 Qtrs |
| Net income attributable to Humana |
NetIncomeLoss
|
$1.20B | USD | 1 Quarter |
| Change in gross unrealized investment losses |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
$-1.98B | USD | 3 Qtrs |
| Change in gross unrealized investment losses |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
$-365.00M | USD | 1 Quarter |
| Change in gross unrealized investment losses |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
$-590.00M | USD | 1 Quarter |
| Change in gross unrealized investment losses |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
$-314.00M | USD | 3 Qtrs |
| Effect of income taxes |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
$-85.00M | USD | 1 Quarter |
| Effect of income taxes |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
$-73.00M | USD | 3 Qtrs |
| Effect of income taxes |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
$-135.00M | USD | 1 Quarter |
| Effect of income taxes |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
$-455.00M | USD | 3 Qtrs |
| Total change in unrealized investment losses, net of tax |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-280.00M | USD | 1 Quarter |
| Total change in unrealized investment losses, net of tax |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-455.00M | USD | 1 Quarter |
| Total change in unrealized investment losses, net of tax |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-1.53B | USD | 3 Qtrs |
| Total change in unrealized investment losses, net of tax |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-241.00M | USD | 3 Qtrs |
| Reclassification adjustment for net realized losses |
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
|
$56.00M | USD | 3 Qtrs |
| Reclassification adjustment for net realized losses |
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
|
$23.00M | USD | 3 Qtrs |
| Reclassification adjustment for net realized losses |
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
|
$3.00M | USD | 1 Quarter |
| Reclassification adjustment for net realized losses |
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
|
$50.00M | USD | 1 Quarter |
| Effect of income taxes |
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
|
$11.00M | USD | 1 Quarter |
| Effect of income taxes |
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
|
- | USD | 1 Quarter |
| Effect of income taxes |
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
|
$5.00M | USD | 3 Qtrs |
| Effect of income taxes |
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
|
$14.00M | USD | 3 Qtrs |
| Total reclassification adjustment, net of tax |
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
$42.00M | USD | 3 Qtrs |
| Total reclassification adjustment, net of tax |
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
$3.00M | USD | 1 Quarter |
| Total reclassification adjustment, net of tax |
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
$39.00M | USD | 1 Quarter |
| Total reclassification adjustment, net of tax |
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
$18.00M | USD | 3 Qtrs |
| Other comprehensive loss, net of tax |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-416.00M | USD | 1 Quarter |
| Other comprehensive loss, net of tax |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-1.51B | USD | 3 Qtrs |
| Other comprehensive loss, net of tax |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-199.00M | USD | 3 Qtrs |
| Other comprehensive loss, net of tax |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-277.00M | USD | 1 Quarter |
| Comprehensive income attributable to Humana |
ComprehensiveIncomeNetOfTax
|
$1.31B | USD | 3 Qtrs |
| Comprehensive income attributable to Humana |
ComprehensiveIncomeNetOfTax
|
$555.00M | USD | 1 Quarter |
| Comprehensive income attributable to Humana |
ComprehensiveIncomeNetOfTax
|
$2.83B | USD | 3 Qtrs |
| Comprehensive income attributable to Humana |
ComprehensiveIncomeNetOfTax
|
$779.00M | USD | 1 Quarter |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.